Number of patients, by age, dispensed hormonal treatments from 2006/07 to 2020/21

OIA response

Thank you for your request dated 15 June 2022 under the Official Information Act 1982 (OIA) for information relating to hormonal treatments. You requested: 

[T]the number of patients being prescribed testosterone treatment, estrogen, progesterones, GnRH Agonists (ie Lupron), anti-androgens (spironolactone, bicalumide, flutamide, finasteride) over the period since 2006 (if available otherwise earliest available full year) to the most recent full year.

Broken down by: 

  • TYPE (testosterone, estrogen, anti-androgens, progesterone, or GnRH analogues), 
  • YEAR (2006 - most recent full year)
  • AGE (0-18 by year, 19+ 5 year age categories are sufficient)
  • SEX (M, F)

Response to your request for information

I am pleased to provide you with the data requested, attached with this response letter. 

Please note that we approach our assessment of requests for information under the OIA on the basis that once we release the information to you it becomes available to any other party in that exact form (whether by you distributing it to others or by virtue of us receiving the same request from a different third party). 

We have redacted a small amount of information from the documents as we consider this is necessary to protect the privacy of natural persons (section 9(2)(a)). 

As required under the OIA, we also considered whether, in the circumstances, the withholding of this information was outweighed by other considerations which render it desirable, in the public interest, to make this information available. In this case we did not consider that the public interest outweighed the reasons for withholding the information. 

Please note you have the right, by way of complaint under section 28(3) of the OIA to an Ombudsman, to seek an investigation and review of our decision.